drugset / Trial / NCT02531906
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
RandomizedParallel-groupOpen-labelSupportive care
Summary
This randomized pilot clinical trial studies the side effects of gabapentin and how well it works when given together with methadone hydrochloride and oxycodone hydrochloride in improving quality of life in patients with stage II-IV head and neck cancer during chemoradiation. Gabapentin, methadone hydrochloride, and oxycodone hydrochloride may help relieve moderate or severe pain caused by head and neck cancer during and after chemoradiation therapy.
Timeline
- Start
- 2015-04-24
- Primary completion
- 2018-06-14
- Completion
- 2018-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | — | Oral |
| Subject | Methadone | Other / unclassified | — | Oral |
| Subject | Oxycodone | Other / unclassified | — | Oral |